BC
Boxer Capital Portfolio holdings
AUM
$2.04B
This Quarter Return
+25.8%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$865M
AUM Growth
+$865M
(+7.5%)
Cap. Flow
-$19.5M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
75.1%
Holding
26
New
3
Increased
4
Reduced
9
Closed
3
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$56.7M |
| 2 |
Biogen
BIIB
|
$47.3M |
| 3 |
Gossamer Bio
GOSS
|
$40.6M |
| 4 |
ALLK
Allakos
ALLK
|
$32.4M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$11M |
Top Sells
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$60.5M |
| 2 |
PTC Therapeutics
PTCT
|
$43.5M |
| 3 |
Wave Life Sciences
WVE
|
$25.3M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$23.8M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$20.4M |
Sector Composition
| 1 | Healthcare | 88.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $126M | 14.54% | 1,715,560 +150,000 | +10% | +$11M |
|
|
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $119M | 13.74% | 900,000 | – | – |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $78.8M | 9.11% | 4,100,000 +2,950,000 | +257% | +$56.7M |
|
|
ODT
4
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $65.9M | 7.62% | 2,978,762 | – | – |
|
5
uniQure
QURE
$896M
| $56.7M | 6.55% | 950,000 -250,000 | -21% | -$14.9M |
|
|
6
Biogen
BIIB
$19.4B
| $47.3M | 5.47% | +200,000 | New | +$47.3M |
|
|
7
Gossamer Bio
GOSS
$562M
| $40.6M | 4.7% | +1,875,000 | New | +$40.6M |
|
8
Esperion Therapeutics
ESPR
$448M
| $39.1M | 4.53% | 975,000 -225,000 | -19% | -$9.03M |
|
|
9
Wave Life Sciences
WVE
$1.53B
| $38.9M | 4.49% | 1,000,000 -650,000 | -39% | -$25.3M |
|
|
10
PTC Therapeutics
PTCT
$3.92B
| $37.6M | 4.35% | 1,000,000 -1,155,000 | -54% | -$43.5M |
|
|
DBVT
11
DBV Technologies
DBVT
$264M
| $32.4M | 3.74% | 4,200,000 -300,000 | -7% | -$2.31M |
|
|
ALLK
12
DELISTED
Allakos
ALLK
| $32.4M | 3.74% | +799,000 | New | +$32.4M |
|
13
Solid Biosciences
SLDB
$427M
| $32M | 3.7% | 3,473,272 -25,000 | -0.7% | -$230K |
|
14
Rocket Pharmaceuticals
RCKT
$354M
| $25.7M | 2.97% | 1,466,051 -500,000 | -25% | -$8.77M |
|
|
MDCO
15
DELISTED
Medicines Co
MDCO
| $16.8M | 1.94% | 600,000 +368,000 | +159% | +$10.3M |
|
|
CBAY
16
DELISTED
Cymabay Therapeutics
CBAY
| $16.6M | 1.92% | 1,250,000 -844,000 | -40% | -$11.2M |
|
17
Kura Oncology
KURA
$686M
| $14M | 1.62% | 844,789 | – | – |
|
|
GBT
18
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $13.2M | 1.53% | 250,000 -450,000 | -64% | -$23.8M |
|
19
Matinas BioPharma
MTNB
$10.1M
| $11.1M | 1.28% | 10,188,312 +4,545,454 | +81% | +$4.95M |
|
20
MEI Pharma
MEIP
$160M
| $8.94M | 1.03% | 2,913,091 | – | – |
|
21
KalVista Pharmaceuticals
KALV
$678M
| $5.72M | 0.66% | 200,000 | – | – |
|
22
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $5.25M | 0.61% | 290,577 | – | – |
|
23
Eledon Pharmaceuticals
ELDN
$155M
| $1.3M | 0.15% | 324,383 | – | – |
|
|
AMRN
24
Amarin Corp
AMRN
$311M
| – | – | -1,500,000 | Closed | -$20.4M |
|
|
ICPT
25
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – | -600,000 | Closed | -$60.5M |
|